Skip to content

Change in AP at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$46.25M-130%
Axogen logo
AxogenAXGN
$2.2M+124%
Globus Medical logo
Globus MedicalGMED
$5.08M+665%
AbbVie logo
AbbVieABBV
-$1.59B-129%
Medtronic logo
MedtronicMDT
$123M-66.4%
STERIS logo
STERISSTE
$56.9M+38.4%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's change in AP?
Integra LifeSciences (IART) reported change in AP of -$19.19M in Q1 2026.
How has Integra LifeSciences's change in AP changed year-over-year?
Integra LifeSciences's change in AP decreased by 6.6% year-over-year, from -$18M to -$19.19M.
What is the long-term trend for Integra LifeSciences's change in AP?
Over 3 years (2021 to 2025), Integra LifeSciences's change in AP has grown at a -7.6% compound annual growth rate (CAGR), from $33.86M to $26.72M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.